Healthcare
Study calls for RSV vaccination for people over 60 in Portugal
A study of 15,000 hospital patients found that adults over 60 hospitalised with Respiratory Syncytial Virus (RSV) face a 18.3% mortality rate and high risks of respiratory failure. The researcher, an internist at the Entre Douro e Vouga Local Health Unit, is calling for the SNS to provide subsidised RSV vaccinations for older adults, which currently cost around 200 euros privately.
Why it mattersIf you are over 60 or have family members in that age group, this highlights a significant health risk, though there is currently no subsidised vaccination programme in place for this demographic.
The Portugal NewsRead original ↗
